🖼
Fig. 3 — RNA splicing and splicing regulator changes in prostate cancer pathology.
active
paper figure
Created: 2026-04-21T18:29:40
By: paper_figures_tool
Quality:
50%
🔗 External
ID: paper-fig-paper-6ec76a6d668d-3
Fig. 3Figure 3
Transcriptional control by a the full-length androgen receptor and b constitutively active AR isoforms made by splice variants. In ( a ), testosterone enters the prostate cancer cell and becomes modified to dihydroxytestosterone (DHT) by 5α-reductase. DHT binds to the androgen receptor (AR), displacing heat shock protein 90 (HSP) and resulting in AR translocation into the nucleus. Once inside the nucleus, the AR binds to consensus DNA sequence elements called androgen response elements (AREs) to control target gene expression. In ( b ), an androgen receptor variant protein (AR-V) lacking the ligand-binding domain is able to directly translocate into the nucleus without binding to DHT, resulting in androgen-independent control of gene expression
▸Metadata
| pmid | paper-6ec76a6d668d |
| caption | Transcriptional control by a the full-length androgen receptor and b constitutively active AR isoforms made by splice variants. In ( a ), testosterone enters the prostate cancer cell and becomes m |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC5602090/bin/439_2017_1792_Fig3_HTML.jpg |
| paper_title | RNA splicing and splicing regulator changes in prostate cancer pathology. |
| figure_label | Fig. 3 |
| figure_number | 3 |
| _schema_version | 1 |
| source_strategy | pmc_api |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.